The upregulation of Nampt is supported by previous studies reporting elevated Nampt in colon tissues from IBD patients and DSS-induced colitis mice counteracting an increased cellular NAD turnover mediated by NAD-depleting enzymes (93–95). The gene discussed is NAMPT; the disease is colitis.